Antenatal corticosteroid treatment: factors other than lung maturation (Q38291466)

1 September 2017

1 reference

title

Antenatal corticosteroid treatment: factors other than lung maturation (English)

1 reference

1 September 2017

Kjell Haram

1

1 reference

1 September 2017

Jan Helge Mortensen

series ordinal

2

1 reference

1 September 2017

Everett F Magann

series ordinal

3

1 reference

1 September 2017

John C Morrison

series ordinal

4

1 reference

1 September 2017

publication date

3 August 2016

1 reference

Journal of Maternal-Fetal and Neonatal Medicine

1 September 2017

published in

1 reference

1 September 2017

volume

30

1 reference

1 September 2017

issue

12

1 reference

1 September 2017

page(s)

1437-1441

1 reference

Epidemiology and causes of preterm birth

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Late-preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Corticosteroids in perinatal medicine: how to improve outcomes without affecting the developing brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Scientific basis and therapeutic regimens for use of antenatal glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Betamethasone dose and formulation for induced lung maturation in fetal sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Controversy: Antenatal Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Antenatal steroids: can we optimize the dose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Antenatal Corticosteroids in the Management of Preterm Birth: Are We Back Where We Started?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD neonatal research network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Transient reduction in fetal activity and heart rate variation after maternal betamethasone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

The effect of betamethasone on fetal biophysical activities and Doppler velocimetry of umbilical and middle cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Effect of antenatal glucocorticoid therapy on arterial and venous blood flow velocity waveforms in severely growth-restricted fetuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Antenatal corticosteroids for periviable birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Influence of a single course of antenatal betamethasone on the maternal-fetal insulin-IGF-GH axis in singleton pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: an evaluation of neonatal outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

The effects of absent or reversed end-diastolic umbilical artery Doppler flow velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Reversed end diastolic flow velocity in viable fetuses: is there time to wait for the effect of corticosteroids before delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Effect of antenatal betamethasone administration on placental vascular resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

Outcomes at 2 Years of Age after Repeat Doses of Antenatal Corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767058.2016.1219716

10.1080/14767058.2016.1219716

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference